Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 473 - Heterocyclic compounds containing purine ring systems
Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
12/1996
12/18/1996EP0748806A1 POLYMORPHS B AND C OF 1- 2,4-DICHLORO-BETA-[(7-CHLOROBENZO[b]THIEN-3-YL)METHOXY]PHENETYL]IMIDAZOLE MONONITRATE
12/18/1996EP0748317A1 Novel thiazolidin-4-one derivatives
12/17/1996US5585492 LTA4 Hydrolase inhibitors
12/17/1996CA1338796C Color photographs, a process for preparing them and color photographic materials employed therefor
12/11/1996EP0746557A1 Intracellular signalling mediators
12/11/1996EP0746326A1 Oligomeric compounds having nitrogen-containing linkages
12/10/1996US5583225 Reacting n2, n9-diprotected guanine with diacetoxypropane in the presence of a mixture of an acid and acetic anhydride
12/10/1996US5583137 Heterocyclic compounds for enhancing antitumor activity
12/04/1996EP0745068A1 Heteroaryl-substituted deoxy glycero-phosphoethanolamines
12/04/1996CN1137274A 6-oxo-nucleosides useful as immunosuppressants
12/03/1996US5580874 Therapy for side effects of immunosuppressive agents
12/03/1996US5580873 Antitumor agents, aids therapy
12/03/1996US5580860 Pharmaceutical composition containing 2-amino-6-chloropurine-9-β-D-2',3'-dideoxyribofuranoxside
11/1996
11/28/1996WO1996030370A3 Thiazole and thiadiazole derivatives, their preparation and pharmaceutical compositions useful in the treatment of thrombocytopenia
11/26/1996CA2069906C Uncharged morpholino-based polymers having achiral intersubunit linkages
11/21/1996WO1996036638A1 Xanthines and their therapeutic use
11/21/1996CA2218548A1 Xanthines and their therapeutic use
11/20/1996EP0742790A1 Substituted purines and oligonucleotide cross-linking
11/20/1996EP0742717A1 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
11/20/1996CN1136277A Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infections
11/20/1996CN1136276A Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections
11/20/1996CN1033326C Process for preparing optically active isomers of 6-substituted purinyl piperazine derivatives
11/20/1996CN1033308C One-seep sublimer for extracting natural caffeine from tea
11/19/1996US5576448 N-(3-hydroxy-4-piperidinyl) (dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
11/19/1996US5576430 Reaction of acetone cyanohydrin and 1,8-diazabicyclo(5.4.0) undec-7-ene in methylene chloride
11/19/1996US5576427 Compounds which replace nucleosides in an oligonucleotide to inhibit nuclease degradation of oligonucleotide
11/13/1996EP0741711A1 Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
11/13/1996EP0741710A1 Chloropyrimide intermediates
11/13/1996CN1135485A 2,9-di-substituted pur-6-ones compound
11/12/1996US5574046 Heteroaryl amines as novel acetylcholinesterase inhibitors
11/06/1996EP0740650A1 Codrugs as a method of controlled drug delivery
11/06/1996CN1135180A Use of penciclorin for the treatment of post-therapeutic neuralgia
10/1996
10/31/1996WO1996033720A1 Use of (r)-penciclovir triphosphate for the manufacture of a medicament for the treatment of viral diseases
10/30/1996EP0739351A1 Monomeric diols and phosphate linked oligomers formed therefrom
10/30/1996EP0739335A1 Pyrrolidine-containing monomers and oligomers
10/30/1996CN1134696A Substituted 5-ring heterocycles, their preparation and their use
10/24/1996WO1996033200A1 Novel compounds and methods for therapy
10/24/1996WO1996033172A1 Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors
10/23/1996EP0738155A1 Modular design and synthesis of oxazolone-derived molecules
10/23/1996CN1133842A Process for preparing doxofylline
10/22/1996US5567816 Hydrolysis of trialkylsilyl-blocked guanine selectively alkylated with 1,3-dioxane
10/22/1996US5567704 Administering to treat hair loss caused by cytoreductive therapies
10/17/1996WO1996016084A3 A method of identifying cftr-binding compounds useful for activating chloride conductance in animal cells
10/15/1996US5565582 Gastrointestinal disorders
10/15/1996US5565566 N6-(endo(1r,2s,4s)-2-norbornyl)-9-methyladenine or n6-(endo(1s,2r,4r)-2-norbornyl)-9-methyladenine
10/15/1996US5565565 One step akylation and concurrently generating the akylation catalyst
10/15/1996US5565551 Non-azo naphthalimide dyes and uses for same
10/15/1996US5565463 9-subtituted-8-unsubstituted-9-deazaguanines
10/15/1996US5565462 Pentoxifylline, propentofylline and(or) torbafylline
10/15/1996US5565461 Treating human immunodeficiency virus
10/09/1996EP0736533A1 Intermediates and process for the preparation of an antiviral agent
10/09/1996EP0736027A1 Guanine synthons for peptide nucleic acid synthesis and method for production
10/09/1996EP0735878A1 Pharmaceuticals
10/09/1996EP0647227B1 Purinone antianginal agents
10/08/1996US5563049 Culture product
10/04/1996CA2172660A1 Intermediates and process for the preparation of an antiviral agent
10/03/1996WO1996030370A2 Thiazole and thiadiazole derivatives, their preparation and pharmaceutical compositions useful in the treatment of thrombocytopenia
10/03/1996WO1996030025A1 Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc
10/03/1996WO1996013498A3 L-erythrosyl nucleosides
10/02/1996EP0734262A1 Use of pentoxifyllin in the treatment of multiple sclerosis
10/01/1996US5561134 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
09/1996
09/25/1996EP0733633A1 Heterocyclic compounds, their production and use
09/25/1996EP0733630A1 Nucleoside derivative
09/25/1996EP0423221B1 Immunosuppressive agents
09/24/1996US5559101 Antitumor, anticarcinogenic, hiv
09/24/1996US5559100 Viricides using aminopurine bases
09/19/1996WO1996028163A1 Adenosine as a positive inotrop in the compromised heart
09/19/1996WO1996010999A3 Lta4 hydrolase inhibitor pharmaceutical compositions and methods of use
09/19/1996CA2213749A1 Adenosine as a positive inotrop in the compromised heart
09/18/1996EP0731807A1 N-2 substituted purines
09/18/1996EP0731702A1 Use of theophylline for the manufacture of a medicament for the treatment of asthma
09/18/1996EP0560794B1 Substituted 1,3-oxathiolanes with antiviral properties
09/18/1996CN1032815C Method for preparation of selective adenosine receptor agents
09/17/1996US5556994 Cyclopropane derivatives and method of preparing the same
09/17/1996US5556862 Pharmaceutical compositions containing isoquinoline derivatives
09/17/1996CA2171932A1 Heterocyclic compounds, their production and use
09/12/1996WO1996027378A2 Use of penciclovir for the treatment of human herpes-virus-8
09/11/1996EP0339086B1 Electrochemiluminescent rhenium moieties and methods
09/11/1996CN1032753C Process for extracting caffeine from tea
09/10/1996US5554772 N-(3-hydroxy-4-piperidinyl) dihydrobenzofuran, (dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
09/10/1996US5554746 Lactam nucleic acids
09/04/1996EP0729460A1 Substituted 5-ring heterocycles, their preparation and their use
09/04/1996CN1130382A Process for preparation of 9-(2-hydroxy)-ethoxymethyl-guanine
09/03/1996US5552553 N-(3-hydroxy-4-piperidinyl) (dihydrobenzofuran, dihydro-2H-benzopyran or dehydrobenzodioxin) carboxamide derivatives
08/1996
08/29/1996WO1996026208A1 Purine compounds and xanthine oxidase inhibitors
08/29/1996CA2213420A1 Purine compounds and xanthine oxidase inhibitors
08/28/1996EP0728757A1 Process for producing purine derivatives
08/28/1996EP0728134A1 6-oxo-nucleosides useful as immunosuppressants
08/28/1996EP0728002A1 Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infection
08/28/1996EP0728001A1 Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections
08/28/1996EP0727959A1 Diagnostic uses of hydrazinoadenosines
08/28/1996EP0523100B1 O6 -benzylated guanine, guanosine and 2'-deoxyguanosine compounds possessing o6 -alkylguanine-dna alkyltransferase depleting activity
08/28/1996CN1032648C Process for preparation of platelet activating factor antagonist
08/27/1996US5550132 Treating septic shock, cachexia, rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, aids
08/27/1996US5550041 Caffeine demethylate gene-containing DNA fragment and microbial process for producing 3-methyl-7-alkylxanthine
08/22/1996WO1996025394A1 Nα-2-(4-NITROPHENULSULFONYL)ETHOXYCARBONYL-AMINO ACIDS
08/22/1996WO1996025184A1 Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
08/20/1996CA1338532C 2',3'-dideoxy purine nucleosides and process for the preparation thereof
08/14/1996EP0725782A1 Novel a 1 adenosine receptor agonists and antiagonists
08/13/1996US5545627 Irreversible inhibitors of adenosine receptors
1 ... 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 ... 120